Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 53

Sort by

Sort Order Select

Journal Articles

Diagnostic Predictive Model for Diagnosis of Heart Failure after Hematopoietic Cell Transplantation (HCT): Comparison of Traditional Statistical with Machine Learning Modeling

Benjamin Djulbegovic, MD, Jennifer Berano Teh, Lennie Wong, PhD, Iztok Hozo, PhD, Saro H. Armenian, DO, MPH

Blood (2019) 134 (Supplement_1): 5799.

https://doi.org/10.1182/blood-2019-130764

Published: 2019

Journal Articles

The Influence of Activity Roles and Use of a Structured Framework on Developing Hematology Clinical Practice Guidelines

Shelly-Anne Li, PhD, Paul Alexander, PhD, Tea Reljic, MPH, Adam Cuker, MD MS, Nieuwlaat Robby, PhD, Wojtek Wiercioch, MD, Gordon Guyatt, MD, Holger Schünemann, MD, Benjamin Djulbegovic, MD

Blood (2018) 132 (Supplement 1): 2237.

https://doi.org/10.1182/blood-2018-99-111367

Published: 2018

Journal Articles

Amino Bisphosphonates Are Associated with Decreased Mortality Compared to Non-Amino Bisphosphonates in the Treatment of Multiple Myeloma

Marianne Razavi, PhD, Rahul Mhaskar, MPH, Benjamin Djulbegovic, MD

Blood (2018) 132 (Supplement 1): 5638.

https://doi.org/10.1182/blood-2018-99-116976

Published: 2018

Journal Articles

How Do ASH Guidelines Panels Make Decisions? Association between Decision Making Factors and the Strength of Recommendations

Benjamin Djulbegovic, MD, Tea Reljic, MPH, Shira Elqayam, PhD, Adam Cuker, MD MS, Iztok Hozo, PhD, Qi Zhou, PhD, Shelly-Anne Li, PhDc), Paul Alexander, PhD, Nieuwlaat Robby, PhD, Wojtek Wiercioch, MD, Holger Schünemann, MD, Gordon Guyatt, MD

Blood (2018) 132 (Supplement 1): 4707.

https://doi.org/10.1182/blood-2018-99-110132

Published: 2018

Journal Articles

Hypomethylating Agents Versus Intensive Chemotherapy in Elderly Patients (Age ≥ 70) with Acute Myeloid Leukemia with High White Blood Cell Count

Chetasi Talati, MD, Andrew Kuykendall, MD, Najla Al Ali, M.Sc, Jongphil Kim, Marina Sehovic, Kenneth S. Zuckerman, MD, David A Sallman, MD, Eric Padron, MD, Alan F. List, MD, Rami S. Komrokji, MD, Benjamin Djulbegovic, MD, Martine Extermann, MD, Kendra L. Sweet, MD, Jeffrey E. Lancet, MD

Blood (2017) 130 (Supplement 1): 3911.

https://doi.org/10.1182/blood.V130.Suppl_1.3911.3911

Published: 2017

Journal Articles

Comparison of Survival Outcomes in Elderly Acute Myeloid Leukemia Patients (Age ≥ 70) When Treated with Azacitidine or Decitabine As an Initial Treatment Modality

Chetasi Talati, MD, Andrew Kuykendall, MD, Najla Al Ali, M.Sc, Jongphil Kim, Marina Sehovic, Kenneth S. Zuckerman, MD, David A Sallman, MD, Alan F List, MD, Eric Padron, MD, Rami S. Komrokji, MD, Benjamin Djulbegovic, MD, Martine Extermann, MD, Kendra Sweet, MD, Jeffrey E. Lancet, MD

Blood (2017) 130 (Supplement 1): 3912.

https://doi.org/10.1182/blood.V130.Suppl_1.3912.3912

Published: 2017

Journal Articles

Effect of NPM1 Mutation on Prognosis and Therapeutic Efficacy in Patients Aged ≥70 Years with Acute Myeloid Leukemia

Chetasi Talati, MD, Andrew Kuykendall, MD, Najla Al Ali, M.Sc, Jongphil Kim, Marina Sehovic, Kenneth S. Zuckerman, MD, David A Sallman, MD, Alan F. List, MD, Eric Padron, MD, Rami S. Komrokji, MD, Benjamin Djulbegovic, MD, Martine Extermann, MD, Kendra Sweet, MD, Jeffrey E. Lancet, MD

Blood (2017) 130 (Supplement 1): 2676.

https://doi.org/10.1182/blood.V130.Suppl_1.2676.2676

Published: 2017

Journal Articles

Predictive Tool to Support Decision-Making about Management of Conflicts of Interest for Guideline Development: Derivation and Validation

Mak Djulbegovic, Stephanie Jaffe, Tea Reljic, Jason Beckstead, Adam Cuker, MD MS, Rob Kunkle, Benjamin Djulbegovic, MD

Blood (2017) 130 (Supplement 1): 4661.

https://doi.org/10.1182/blood.V130.Suppl_1.4661.4661

Published: 2017

Journal Articles

Outcomes in Older Adults (age ≥ 70) with Acute Myeloid Leukemia Based on Choice of Frontline Treatment for Proliferative or Non-Proliferative Phenotype

Blood (2017) 130 (Supplement 1): 1412.

https://doi.org/10.1182/blood.V130.Suppl_1.1412.1412

Published: 2017

Journal Articles

Negative Impact of FLT3-ITD Mutation in Elderly Acute Myeloid Leukemia Patients (Age ≥70) Is Karyotype Dependent

Blood (2017) 130 (Supplement 1): 1413.

https://doi.org/10.1182/blood.V130.Suppl_1.1413.1413

Published: 2017

Journal Articles

Improving Hospice Referral: Application of Regret-Based Decision Modeling at End-of-Life Care

Benjamin Djulbegovic, MD PhD, Athanasios Tsalatsanis, PhD, Rahul Mhaskar, MPH, PhD, Iztok Hozo, PhD, Branko Miladinovic, PhD, Howard Tuch, MD PhD

Blood (2016) 128 (22): 535.

https://doi.org/10.1182/blood.V128.22.535.535

Published: 2016

Journal Articles

Type of Therapy May Influence Outcomes in Patients over Age 70 with Acute Myeloid Leukemia: A Systematic Review of More Than 11,000 Patients

Martine Extermann, MD PhD, Marina Sehovic, MD MPH, Tea Reljic, MPH, Jongphil Kim, PhD, Jeffrey E. Lancet, MD, Benjamin Djulbegovic, MD PhD

Blood (2016) 128 (22): 3998.

https://doi.org/10.1182/blood.V128.22.3998.3998

Published: 2016

Journal Articles

When Should Patients Older Than 70 with Acute Myeloid Leukemia be Treated?

Jongphil Kim, Martine Extermann, MD PhD, Jeffrey E. Lancet, MD, Najla H Al Ali, Tea Reljic, MPH, Marina Sehovic, MD MPH, Varun C Dhulipala, MD, Benjamin Djulbegovic, MD PhD

Blood (2016) 128 (22): 4007.

https://doi.org/10.1182/blood.V128.22.4007.4007

Published: 2016

Journal Articles

Survival Comparison Amongst Commonly Used Frontline Regimens in Patients Age 70 Years and Older with Acute Myeloid Leukemia (AML): A Single-Institution Study of over 600 Patients

Varun C Dhulipala, MD, Martine Extermann, MD PhD, Najla Al Ali, Jongphil Kim, Marina Sehovic, MD MPH, Tea Reljic, Benjamin Djulbegovic, MD PhD, Jeffrey E Lancet, MD

Blood (2015) 126 (23): 2505.

https://doi.org/10.1182/blood.V126.23.2505.2505

Published: 2015

Journal Articles

Meta-Analysis Evaluating Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation As Front-Line Consolidation in Chronic Lymphocytic Leukemia: Results Do Not Justify This Treatment Approach

Tea Reljic, M.S., Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD, Mohamed A Kharfan-Dabaja, MD

Blood (2014) 124 (21): 1306.

https://doi.org/10.1182/blood.V124.21.1306.1306

Published: 2014

Journal Articles

A Strong Correlation Between Spot Urine Protein To Creatinine Ratio and 24-Hour Urine Protein Quantification For Proteinuria Assessment In Patients With Plasma Cell Dyscrasia

Apuri Susmitha, MD, Taiga Nishihori, MD, Karen Lin, MD, Rachid Baz, MD, Binglin Yue, MS, Jongphil Kim, PhD, Kenneth H. Shain, MD, PhD, Elias Doumit, MD, Jose L Ochoa-Bayona, MD, Daniel M Sullivan, MD, Melissa Alsina, MD, Benjamin Djulbegovic, MD, PhD

Blood (2013) 122 (21): 3155.

https://doi.org/10.1182/blood.V122.21.3155.3155

Published: 2013

Journal Articles

Efficacy Of Novel Agents As Maintenance Therapy For Multiple Myeloma: A Direct and Network Meta-Analysis

Tea Reljic, BS, Ambuj Kumar, MD, MPH, Helen Mahoney, MPH, Branko Miladinovic, PhD, Mohamed A Kharfan-Dabaja, MD, Rahul Mhaskar, MPH, PhD, Benjamin Djulbegovic, MD, PhD

Blood (2013) 122 (21): 1945.

https://doi.org/10.1182/blood.V122.21.1945.1945

Published: 2013

Journal Articles

Conservative Management Vs. Allogeneic Hematopoietic Cell Transplantation For Polycythemia Vera: A Systematic Review and Decision-Analysis

Jasmin Lacevic, Tea Reljic, BS, Najla El Jurdi, MD, Mohamed A Kharfan-Dabaja, MD, Taiga Nishihori, MD, Rami S. Komrokji, MD, Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD

Blood (2013) 122 (21): 5372.

https://doi.org/10.1182/blood.V122.21.5372.5372

Published: 2013

Journal Articles

Comparative Efficacy of Tandem Autologous Versus Autologous Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis

Mohamed A. Kharfan-Dabaja, MD, Mehdi Hamadani, M.D, Tea Reljic, William I. Bensinger, MD, Benjamin Djulbegovic, MD, PhD, Ambuj Kumar, MD, MPH

Blood (2012) 120 (21): 4519.

https://doi.org/10.1182/blood.V120.21.4519.4519

Published: 2012

Journal Articles

Maintenance Therapies for Multiple Myeloma (MM): A Direct Meta-Analysis

Helen Mahony, MPH, Ambuj Kumar, MD, MPH, Rahul Mhaskar, MPH, PhD, Branko Miladinovic, PhD, Keith Wheatley, Benjamin Djulbegovic, MD, PhD

Blood (2012) 120 (21): 4271.

https://doi.org/10.1182/blood.V120.21.4271.4271

Published: 2012

NARROW

Diagnostic Predictive Model for Diagnosis of Heart Failure after Hematopoietic Cell Transplantation (HCT): Comparison of Traditional Statistical with Machine Learning Modeling

The Influence of Activity Roles and Use of a Structured Framework on Developing Hematology Clinical Practice Guidelines

Amino Bisphosphonates Are Associated with Decreased Mortality Compared to Non-Amino Bisphosphonates in the Treatment of Multiple Myeloma

How Do ASH Guidelines Panels Make Decisions? Association between Decision Making Factors and the Strength of Recommendations

Hypomethylating Agents Versus Intensive Chemotherapy in Elderly Patients (Age ≥ 70) with Acute Myeloid Leukemia with High White Blood Cell Count

Comparison of Survival Outcomes in Elderly Acute Myeloid Leukemia Patients (Age ≥ 70) When Treated with Azacitidine or Decitabine As an Initial Treatment Modality

Effect of NPM1 Mutation on Prognosis and Therapeutic Efficacy in Patients Aged ≥70 Years with Acute Myeloid Leukemia

Predictive Tool to Support Decision-Making about Management of Conflicts of Interest for Guideline Development: Derivation and Validation

Outcomes in Older Adults (age ≥ 70) with Acute Myeloid Leukemia Based on Choice of Frontline Treatment for Proliferative or Non-Proliferative Phenotype

Negative Impact of FLT3-ITD Mutation in Elderly Acute Myeloid Leukemia Patients (Age ≥70) Is Karyotype Dependent

Improving Hospice Referral: Application of Regret-Based Decision Modeling at End-of-Life Care

Type of Therapy May Influence Outcomes in Patients over Age 70 with Acute Myeloid Leukemia: A Systematic Review of More Than 11,000 Patients

When Should Patients Older Than 70 with Acute Myeloid Leukemia be Treated?

Survival Comparison Amongst Commonly Used Frontline Regimens in Patients Age 70 Years and Older with Acute Myeloid Leukemia (AML): A Single-Institution Study of over 600 Patients

Meta-Analysis Evaluating Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation As Front-Line Consolidation in Chronic Lymphocytic Leukemia: Results Do Not Justify This Treatment Approach

A Strong Correlation Between Spot Urine Protein To Creatinine Ratio and 24-Hour Urine Protein Quantification For Proteinuria Assessment In Patients With Plasma Cell Dyscrasia

Efficacy Of Novel Agents As Maintenance Therapy For Multiple Myeloma: A Direct and Network Meta-Analysis

Conservative Management Vs. Allogeneic Hematopoietic Cell Transplantation For Polycythemia Vera: A Systematic Review and Decision-Analysis

Comparative Efficacy of Tandem Autologous Versus Autologous Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis

Maintenance Therapies for Multiple Myeloma (MM): A Direct Meta-Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only